LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Deutsche Bank Health Care Conference on Monday, May 18, 2009 at 1:45 pm (ET) at the InterContinental Boston Hotel.
